Seattle Genetics CEO Clay Siegall's comp package soars to $18.1M, rivaling Big Pharma chiefs
After taking shareholders on something of a roller coaster ride last year, Seattle Genetics CEO Clay Siegall rewarded himself with a compensation package that swelled to more than twice the size of his financial reward for 2017.
Adding significantly to his columns on stock awards and options, Siegall’s compensation soared to $18.1 million last year, up from $8.6 million in 2017 and the $9.5 million package he garnered the year before that. That put his compensation at a multiple of 91 over the average salary at Seattle Genetics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.